BRIACELL THERAPEUTICS CORP. (BCTXL) Free cash flow 2024–2026
BRIACELL THERAPEUTICS CORP. (BCTXL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.8MFY2026 · since FY2024: -$24.6M → -$28.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$28.8M | — |
| FY2024 | -$24.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXL financial trends
BCTXL RevenueBCTXL Net incomeBCTXL Net marginBCTXL Gross profitBCTXL Gross marginBCTXL Operating incomeBCTXL Operating marginBCTXL Operating cash flowBCTXL Capital expendituresBCTXL Return on equityBCTXL Stock buybacksBCTXL Dividends paidBCTXL Total assetsBCTXL Total liabilitiesBCTXL Shareholders’ equityBCTXL overview →